Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.4.1 (
cytosine deaminase
)
747
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
APOBEC3G has an important role in human defense against retroviral pathogens, including HIV-1. Its single-stranded DNA
cytosine deaminase
activity, located in its C-terminal domain (A3Gctd), can mutate viral cDNA and restrict infectivity. We used time-resolved nuclear magnetic resonance (NMR) spectroscopy to determine kinetic parameters of A3Gctd's deamination reactions within a 5'-
CCC
hot spot sequence. A3Gctd exhibited a 45-fold preference for 5'-
CCC
substrate over 5'-CCU substrate, which explains why A3G displays almost no processivity within a 5'-
CCC
motif. In addition, A3Gctd's shortest substrate sequence was found to be a pentanucleotide containing 5'-
CCC
flanked on both sides by a single nucleotide. A3Gctd as well as full-length A3G showed peak deamination velocities at pH 5.5. We found that H216 is responsible for this pH dependence, suggesting that protonation of H216 could play a key role in substrate binding. Protonation of H216 appeared important for HIV-1 restriction activity as well, since substitutions of H216 resulted in lower restriction in vivo.
...
PMID:Impact of H216 on the DNA binding and catalytic activities of the HIV restriction factor APOBEC3G. 2359 92